TNFSF10 and chronic myelogenous leukemia, BCR-ABL1 positive: Since it has been suggested that the hematopoietic niche could induce a TRAIL-mediated apoptosis, investigation of this pathway in the context of CML resistance (especially with ponatinib) could be of importance [37,38].